33 related articles for article (PubMed ID: 11978192)
1. A Novel 3-
Moralev AD; Salomatina OV; Chernikov IV; Salakhutdinov NF; Zenkova MA; Markov AV
ACS Omega; 2023 Dec; 8(51):48813-48824. PubMed ID: 38162726
[TBL] [Abstract][Full Text] [Related]
2. Potential for cardiac toxicity with methylimidazolium ionic liquids.
Abdelghany TM; Hedya SA; De Santis C; Abd El-Rahman SS; Gill JH; Abdelkader NF; Wright MC
Ecotoxicol Environ Saf; 2023 Jan; 249():114439. PubMed ID: 37272551
[TBL] [Abstract][Full Text] [Related]
3. Daurisoline Inhibiting Tumor Angiogenesis and Epithelial-Mesenchymal Transition in Bladder Cancer by Mediating HAKAI Protein Stability.
Huang K; Chen Q; Deng L; Zou Q; Min S
Iran J Pharm Res; 2022 Dec; 21(1):e129798. PubMed ID: 36937208
[TBL] [Abstract][Full Text] [Related]
4. Chemosensitizing effect and mechanism of imperatorin on the anti-tumor activity of doxorubicin in tumor cells and transplantation tumor model.
Liang XL; Ji MM; Liao ZG; Zhao GW; Tang XL; Dong W
Korean J Physiol Pharmacol; 2022 May; 26(3):145-155. PubMed ID: 35477542
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicles in Chemoresistance.
De Rubis G; Bebawy M
Subcell Biochem; 2021; 97():211-245. PubMed ID: 33779919
[TBL] [Abstract][Full Text] [Related]
6. Nonspecifically enhanced therapeutic effects of vincristine on multidrug-resistant cancers when coencapsulated with quinine in liposomes.
Xu Y; Qiu L
Int J Nanomedicine; 2015; 10():4225-37. PubMed ID: 26170660
[TBL] [Abstract][Full Text] [Related]
7. Alkaloids in Processed Rhizoma Corydalis and Crude Rhizoma Corydalis Analyzed by GC/MS.
Guo Z; Cai R; Su H; Li Y
J Anal Methods Chem; 2014; 2014():281342. PubMed ID: 25210643
[TBL] [Abstract][Full Text] [Related]
8. Marine natural products with P-glycoprotein inhibitor properties.
Lopez D; Martinez-Luis S
Mar Drugs; 2014 Jan; 12(1):525-46. PubMed ID: 24451193
[TBL] [Abstract][Full Text] [Related]
9. Changes in P-glycoprotein activity are mediated by the growth of a tumour cell line as multicellular spheroids.
Ponce de León V; Barrera-Rodríguez R
Cancer Cell Int; 2005 Jul; 5(1):20. PubMed ID: 16001980
[TBL] [Abstract][Full Text] [Related]
10. Functional expression and localization of P-glycoprotein at the blood brain barrier.
Bendayan R; Lee G; Bendayan M
Microsc Res Tech; 2002 Jun; 57(5):365-80. PubMed ID: 12112443
[TBL] [Abstract][Full Text] [Related]
11. Multiple recognition of various amphiphilic molecules by the multidrug resistance P-glycoprotein: molecular mechanisms and pharmacological consequences coming from functional interactions between various drugs.
Orlowski S; Garrigos M
Anticancer Res; 1999; 19(4B):3109-23. PubMed ID: 10652600
[TBL] [Abstract][Full Text] [Related]
12. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier.
He L; Liu GQ
Acta Pharmacol Sin; 2002 May; 23(5):423-9. PubMed ID: 11978192
[TBL] [Abstract][Full Text] [Related]
13. Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells.
He L; Liu GQ
Acta Pharmacol Sin; 2002 Jul; 23(7):591-6. PubMed ID: 12100750
[TBL] [Abstract][Full Text] [Related]
14. Interaction of CJZ3, a lomerizine derivative, with ATPase activity of human P-glycoprotein in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Ji BS; Li M; He L
Pharmazie; 2010 Jul; 65(7):515-9. PubMed ID: 20662321
[TBL] [Abstract][Full Text] [Related]
15. P glycoprotein regulated transport of glutamate at blood brain barrier.
Liu XD; Liu GQ
Acta Pharmacol Sin; 2001 Feb; 22(2):111-6. PubMed ID: 11741514
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
